ReviewJournal of cancer research and clinical oncology2026
Artificial intelligence construction: a review of the bridge between CT imaging features of lung ground-glass nodules adenocarcinoma and carcinogenic driver genes.
Review in Journal of cancer research and clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on "Artificial intelligence construction: a review of the bridge between CT imaging features of lung ground-glass nodules adenocarcinoma and carcinogenic driver genes".Journal of cancer research and clinical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung ground-glass nodules (GGNs) represent a critical early imaging manifestation of lung adenocarcinoma, and exploring the relationship between their CT imaging features and oncogenic driver genes holds significant promise for precision diagnosis and personalized treatment. In recent years, artificial intelligence (AI) technologies, particularly deep learning and machine learning methods, have demonstrated remarkable potential in the integrative analysis of radiomic and genomic data. This review summarizes the current advances in AI applications for extracting CT imaging features of lung GGNs, identifying oncogenic driver genes, and analyzing their correlations. Key AI-driven techniques enabling the construction of a bridge between imaging phenotypes and genetic alterations are discussed, alongside challenges such as data heterogeneity, limited annotated datasets, and interpretability. Future research directions emphasize the development of robust, explainable AI models and multi-omics integration to enhance early lung cancer diagnosis and therapeutic strategies. By providing a comprehensive overview of the intersection between AI, radiomics, and genomics in lung GGN adenocarcinoma, this article aims to offer theoretical insights and technical references to advance early detection and precision oncology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.